GSDMB and cervical cancer: Moreover, Sun et al. [17] demonstrated by IHC a 72.7% (16/22) positive nuclear GSDMB expression rate in uterine cervix cancer samples and 33.3% (5/15) in normal samples, showing a similar positive rate of nuclear GSDMB expression in cancer tissues to ours (67.8%) but a lower positive rate in normal tissues.